Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A random-effects Markov transition model for Poisson-distributed repeated measures with non-ignorable missing values.

Jinhui Li1, Xiaowei Yang, Yingnian Wu

  • 1UCLA-Department of Statistics, PO Box 951554, Los Angeles, CA 90095-1554, USA.

Statistics in Medicine
|November 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-Scale Fusion for Real-Time Image Observation and Data Analysis of Athletes after Soft Tissue Injury.

Current medical imaging·2025
Same author

Respiratory Failure Associated With Mutations in the RYR1 Gene: A Case Report.

Clinical case reports·2025
Same author

Inequities from the Embedded Plastic Flow and Carbon Footprint Transfers in International Trade.

Environmental science & technology·2025
Same author

Molecular insights into the persistence and co-occurrence of two different carbapenem-resistant <i>Pseudomonas aeruginosa</i> lineages within a hospital setting.

Microbiology spectrum·2025
Same author

A comprehensive benchmarking of adaptive sampling tools for nanopore sequencing.

Genome biology·2025
Same author

Longitudinal Patterns of Cardiovascular Disease and Cancer Mortality in Renal Cell Carcinoma Patients by Tumor Stage.

JACC. CardioOncology·2025

This study introduces a novel statistical model for analyzing longitudinal biomedical data with missing values. The method accurately models disease progression and missing data patterns in chronic diseases, improving data analysis for clinical trials.

Area of Science:

  • Biostatistics
  • Longitudinal Data Analysis
  • Missing Data Methods

Background:

  • Longitudinal studies in biomedical research often face challenges with missing data due to non-response or withdrawal.
  • These missing values are frequently 'non-ignorable,' meaning they are related to the underlying disease process and missingness patterns.
  • Accurate modeling of both disease progression and missing data is crucial for reliable analysis.

Purpose of the Study:

  • To develop and validate a statistical framework for analyzing incomplete repeated count measures in longitudinal biomedical studies.
  • To address the 'non-ignorable' missing data mechanism by integrating it with the disease process model.
  • To provide a robust method for estimating transition probabilities in chronic disease progression and missingness.

Main Methods:

Related Experiment Videos

  • A shared-parameter framework was employed to model the count process and the missing-data mechanism separately but conditionally.
  • Random-effects Markov transition models were developed using Markov Chain Monte Carlo (MCMC) algorithms.
  • Poisson regression was used for estimating transition probabilities of count measures, and multinomial-logit regression for missingness indicators.

Main Results:

  • The developed Markov Chain Monte Carlo algorithms successfully fit the random-effects Markov transition model for incomplete count data.
  • The method effectively estimates transition probabilities for both the disease process and the missing data mechanism.
  • Validation was performed using both simulated datasets and a real-world smoking cessation clinical trial dataset.

Conclusions:

  • The proposed random-effects Markov transition model provides a powerful tool for analyzing longitudinal count data with non-ignorable missingness.
  • This approach enhances the accuracy of analyzing disease progression in chronic conditions and missing data patterns.
  • The method demonstrates practical utility in clinical trial settings, such as smoking cessation studies.